Monitoring of COVID-19 patients by telemedicine with telemonitoring
© 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved..
AIM: To asses if telemedicine with telemonitoring is a clinically useful and secure tool in the tracking of patients with COVID-19.
METHODS: A prospective observational study of patients with COVID-19 diagnosis by positive PCR considered high-risk tracked with telemedicine and telemonitoring was conducted in the sanitary area of Lugo between March 17th and April 17th, 2020. Two groups of patients were included: Outpatient Tracing from the beginning and after discharge. Every patient sent a daily clinical questionnaire with temperature and oxygen saturation 3 times a day. Proactive monitoring was done by getting in touch with every patient at least 11 a day.
RESULTS: 313 patients (52.4% female) with a total average age of 60.9 (DE 15.9) years were included. Additionally, 2 patients refused to join the program. Since the beginning, 224 were traced outpatient and 89 after being discharged. Among the first category, 38 (16.90%) were referred to Emergency department on 43 occasions; 18 were hospitalized (8.03%), and 2 deceased. Neither deaths nor a matter of vital emergency occurred at home. When including patients after admissions monitoring was done in 304 cases. One patient re-entered (0.32%) to the hospital, and another one left the program (0.32%). The average time of monitoring was 11.64 (SD 3.58) days, and 224 (73.68%) patients were discharged during the 30 days of study.
CONCLUSIONS: Our study suggests that telemedicine with home telemonitoring, used proactively, allows for monitoring high-risk patients with COVID-19 in a clinically useful and secure way.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:220 |
|---|---|
| Enthalten in: |
Revista clinica espanola - 220(2020), 8 vom: 17. Nov., Seite 472-479 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Telemedicina con telemonitorización en el seguimiento de pacientes con COVID-19 |
|---|
| Beteiligte Personen: |
Martínez-García, M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 23.04.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.rce.2020.05.013 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM325458596 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM325458596 | ||
| 003 | DE-627 | ||
| 005 | 20231225192500.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.1016/j.rce.2020.05.013 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1084.xml |
| 035 | |a (DE-627)NLM325458596 | ||
| 035 | |a (NLM)33994572 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Martínez-García, M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Monitoring of COVID-19 patients by telemedicine with telemonitoring |
| 246 | 3 | 3 | |a Telemedicina con telemonitorización en el seguimiento de pacientes con COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved. | ||
| 520 | |a AIM: To asses if telemedicine with telemonitoring is a clinically useful and secure tool in the tracking of patients with COVID-19 | ||
| 520 | |a METHODS: A prospective observational study of patients with COVID-19 diagnosis by positive PCR considered high-risk tracked with telemedicine and telemonitoring was conducted in the sanitary area of Lugo between March 17th and April 17th, 2020. Two groups of patients were included: Outpatient Tracing from the beginning and after discharge. Every patient sent a daily clinical questionnaire with temperature and oxygen saturation 3 times a day. Proactive monitoring was done by getting in touch with every patient at least 11 a day | ||
| 520 | |a RESULTS: 313 patients (52.4% female) with a total average age of 60.9 (DE 15.9) years were included. Additionally, 2 patients refused to join the program. Since the beginning, 224 were traced outpatient and 89 after being discharged. Among the first category, 38 (16.90%) were referred to Emergency department on 43 occasions; 18 were hospitalized (8.03%), and 2 deceased. Neither deaths nor a matter of vital emergency occurred at home. When including patients after admissions monitoring was done in 304 cases. One patient re-entered (0.32%) to the hospital, and another one left the program (0.32%). The average time of monitoring was 11.64 (SD 3.58) days, and 224 (73.68%) patients were discharged during the 30 days of study | ||
| 520 | |a CONCLUSIONS: Our study suggests that telemedicine with home telemonitoring, used proactively, allows for monitoring high-risk patients with COVID-19 in a clinically useful and secure way | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a COVID-19 management | |
| 650 | 4 | |a Case management | |
| 650 | 4 | |a Telemedicine | |
| 700 | 1 | |a Bal-Alvarado, M |e verfasserin |4 aut | |
| 700 | 1 | |a Santos Guerra, F |e verfasserin |4 aut | |
| 700 | 1 | |a Ares-Rico, R |e verfasserin |4 aut | |
| 700 | 1 | |a Suárez-Gil, R |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-Álvarez, A |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-López, A |e verfasserin |4 aut | |
| 700 | 1 | |a Casariego-Vales, E |e verfasserin |4 aut | |
| 700 | 0 | |a en nombre del Equipo de Seguimiento Compartido TELEA-COVID Lugo |e verfasserin |4 aut | |
| 700 | 0 | |a Equipo TELEA COVID-19 (Lugo) |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista clinica espanola |d 1947 |g 220(2020), 8 vom: 17. Nov., Seite 472-479 |w (DE-627)NLM000023043 |x 0014-2565 |7 nnns |
| 773 | 1 | 8 | |g volume:220 |g year:2020 |g number:8 |g day:17 |g month:11 |g pages:472-479 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.rce.2020.05.013 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 220 |j 2020 |e 8 |b 17 |c 11 |h 472-479 | ||